Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Oryzon Genomics SA (DE:ORN)
STUTTGART:ORN
RESEARCH TOOLSreports
Oryzon Genomics SA (ORN) Stock Price & Analysis
0 Followers
ORN Stock Chart & Stats
Day’s Range€0 - €0
52-Week Range€1.58 - €2.26
Previous Close€1.89
Volume0.00
Average Volume (3M)386.00
Market Cap
€119.87M
Enterprise Value€116.00M
Total Cash (Recent Filing)€21.32M
Total Debt (Recent Filing)€17.44M
Price to Earnings (P/E)N/A
Beta0.13
Next Earnings
May 03, 2024EPS Estimate
-€0.03Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. VolumeN/A
30 Day Avg. Volume386
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Oryzon Genomics SA News
ORN FAQ
What was Oryzon Genomics SA’s price range in the past 12 months?
Oryzon Genomics SA lowest stock price was €1.58 and its highest was €2.25 in the past 12 months.
What is Oryzon Genomics SA’s market cap?
Currently, no data Available
When is Oryzon Genomics SA’s upcoming earnings report date?
Oryzon Genomics SA’s upcoming earnings report date is May 03, 2024 which is 3 days ago.
How were Oryzon Genomics SA’s earnings last quarter?
Oryzon Genomics SA released its earnings results on Feb 26, 2024. The company reported -€0.028 earnings per share for the quarter, beating the consensus estimate of -€0.052 by €0.024.
Is Oryzon Genomics SA overvalued?
According to Wall Street analysts Oryzon Genomics SA’s price is currently Overvalued.
Does Oryzon Genomics SA pay dividends?
Oryzon Genomics SA does not currently pay dividends.
What is Oryzon Genomics SA’s EPS estimate?
Oryzon Genomics SA’s EPS estimate is -€0.03.
How many shares outstanding does Oryzon Genomics SA have?
Currently, no data Available
What happened to Oryzon Genomics SA’s price movement after its last earnings report?
Oryzon Genomics SA reported an EPS of -€0.028 in its last earnings report, beating expectations of -€0.052. Following the earnings report the stock price went down -1.075%.
Which hedge fund is a major shareholder of Oryzon Genomics SA?
Currently, no hedge funds are holding shares in DE:ORN
---
Oryzon Genomics SA Stock Smart Score
Not Ranked
1
2
3
4
5
6
7
8
9
10
Company Description
Oryzon Genomics SA
Oryzon Genomics SA is a clinical stage biopharmaceutical company and engaged in the development of epigenetics-based therapeutics. It is engaged in the field of epigenetic medicine and in the development of therapeutic, biological solutions for cancer and neurodegenerative diseases.
---
Technical Analysis
---